US Pre-Market SEC Filings Roundup — February 26, 2026

27-02-2026

Amneal Pharmaceuticals, Inc. filed an 8-K on February 27, 2026, disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific quantitative financial metrics, comparisons, positive or negative changes, or other details are provided in the filing information.

27-02-2026

Cigna Group filed an 8-K on February 27, 2026 (AccNo: 0001140361-26-007049, Size: 162 KB) under Item 7.01 for Regulation FD Disclosure. No specific core event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. All details on impacts, guidance, or scheduled events remain NOT_DISCLOSED.

27-02-2026

AIR Industries Group filed an 8-K on February 27, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement's terms, parties, value, financial impact, or any quantitative metrics are provided.

27-02-2026

Limitless X Holdings Inc. filed a Form 8-K on February 27, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific details such as transaction value, parties, terms, financial metrics, or impacts are disclosed.

27-02-2026

Datavault AI Inc. filed an 8-K on February 27, 2026 (AccNo: 0001104659-26-020936), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, guidance changes, or operational details were disclosed. This represents a material negative development with no mentioned positives or offsets.

27-02-2026

Ultra Clean Holdings, Inc. filed a Form 8-K on February 27, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, events, financial impacts, or quantitative metrics are disclosed. This is a multi-item filing with no period-over-period comparisons, guidance, or named entities beyond the filer provided.

27-02-2026

Verde Resources, Inc. filed a Form 8-K on February 27, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely related to a shareholder meeting. No specific matters, voting results, outcomes, or any quantitative data such as vote percentages, share counts, or financial implications are disclosed in the provided filing information. This appears to be a mandatory, single-item informational disclosure with no evident positive or negative metrics.

27-02-2026

BrightSpring Health Services, Inc. filed an 8-K on February 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results with attached exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.

• ·Accession Number: 0001193125-26-078998
• ·File Size: 1 MB

27-02-2026

27-02-2026

Flutter Entertainment plc filed an 8-K on February 27, 2026 (AccNo: 0001193125-26-078977, Size: 139 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing discloses material information publicly to comply with Regulation FD, with exhibits attached, but specific content details are NOT_DISCLOSED. No financial metrics, transactions, or performance data (positive, negative, or flat) are mentioned.

27-02-2026

Escalade Inc filed an 8-K on February 27, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This multi-item filing provides metadata on the earnings release but lacks detailed financial data for analysis.

27-02-2026

Ginkgo Bioworks Holdings, Inc. filed an 8-K on 2026-02-27 disclosing entry into a Material Definitive Agreement under Item 1.01. The filing also reports Financial Statements and Exhibits under Item 9.01. No specific details on the agreement terms, transaction value, parties involved, financial impacts, or other metrics are disclosed.

27-02-2026

Bain Capital Specialty Finance, Inc. filed an 8-K on February 27, 2026, disclosing information under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, transaction details, or guidance are provided in the filing summary. This appears to be a multi-item voluntary or mandatory earnings-related disclosure, but quantitative impacts are NOT_DISCLOSED.

27-02-2026

Abony Acquisition Corp. I filed an 8-K on 2026-02-27 disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on merger or acquisition structure, parties, valuation, synergies, or impacts are provided in the filing summary. Sector is not specified, and no quantitative metrics, comparisons, or scheduled events are mentioned.

• ·AccNo: 0001213900-26-021014
• ·Filing size: 422 KB

27-02-2026

Golden Entertainment, Inc. filed a Form 8-K on February 27, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or performance indicators (positive, negative, or flat) are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with no quantified impacts available.

27-02-2026

Matador Resources Co filed an 8-K on 2026-02-27 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided. No quantitative metrics, positive or negative changes, or financial impacts are disclosed.

• ·Filing Accession Number: 0001104659-26-020877
• ·Filing Size: 500 KB
• ·Sector: NOT_DISCLOSED

27-02-2026

FrontView REIT, Inc. filed a Form 8-K on February 27, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction values, share counts, or financial metrics disclosed in the provided information. No positive or negative performance metrics are mentioned.

27-02-2026

Sunoco LP filed a Form 8-K on February 27, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing indicating voluntary disclosure of material information previously shared selectively with certain parties, with exhibits attached. No specific details, financial metrics, transactions, or performance data are disclosed.

27-02-2026

Goldman Sachs BDC, Inc. filed an 8-K on February 27, 2026 (AccNo: 0001193125-26-078362), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are NOT_DISCLOSED. No positive or negative metrics, scheduled events, or transactions detailed in the provided filing information.

27-02-2026

Northwest Natural Holding Co filed an 8-K on February 27, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. This multi-item filing reports financial results but provides no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons in the available information. No quantitative metrics, positive or negative changes, or strategic updates are explicitly stated.

27-02-2026

The company filed an 8-K on February 27, 2026, disclosing entry into a new Material Definitive Agreement under Item 1.01 and termination of a prior Material Definitive Agreement under Item 1.02, alongside other events in Item 8.01 and financial statements/exhibits in Item 9.01. No specific details on the nature, parties, terms, or financial impacts of the agreements are disclosed. This appears to be a replacement or amendment of a prior agreement, but without further context, the net impact remains unclear.

27-02-2026

News Corp filed an 8-K on February 27, 2026 (AccNo: 0001564708-26-000043, size 399 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Specific details of the other events or attached exhibits are NOT_DISCLOSED. No financial metrics, transactions, or performance data are mentioned.

27-02-2026

Duolingo, Inc. filed a Form 8-K on 2026-02-27 under Item 2.02 announcing Results of Operations and Financial Condition, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This represents a standard earnings-related disclosure.

27-02-2026

VSE Corp filed an 8-K on February 27, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the financial statements and exhibits are provided in the filing summary. No quantitative metrics, transactions, or forward-looking information are disclosed.

27-02-2026

Graphic Packaging Holding Co filed an 8-K on 2026-02-27 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on transaction terms, size, parties, or financial impacts provided in the available information. No quantitative metrics, positive or negative performance indicators, or period-over-period comparisons are mentioned.

27-02-2026

Xeris Biopharma Holdings, Inc. filed an 8-K on 2026-02-27 reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material nonpublic information and attached exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing metadata.

27-02-2026

Anteris Technologies Global Corp. filed an 8-K on February 27, 2026 (AccNo: 0001140361-26-007003), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item voluntary disclosure of financial results. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information.

27-02-2026

Trimas Corp filed an 8-K on 2026-02-27 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections or appointments of directors/officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

27-02-2026

UWM Holdings Corp filed an 8-K on February 27, 2026 (AccNo: 0001783398-26-000018, size 3 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, financial metrics, transactions, or exhibits provided. No quantitative data, period-over-period comparisons, or directional metrics are mentioned.

27-02-2026

Larimar Therapeutics, Inc. filed an 8-K on February 27, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or strategic context are mentioned.

27-02-2026

Carter's Inc. filed an 8-K on 2026-02-27 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information.

27-02-2026

Delek US Holdings, Inc. filed an 8-K on 2026-02-27 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item voluntary disclosure pertains to financial results. No quantitative metrics, period-over-period comparisons, guidance, or other specific financial details are disclosed.

27-02-2026

Delek Logistics Partners, LP filed an 8-K on 2026-02-27 disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

27-02-2026

INTEST CORP filed an 8-K on February 27, 2026 (AccNo: 0001036262-26-000004, Size: 925 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no detailed performance data available.

27-02-2026

Via Transportation, Inc. filed a Form 8-K on 2026-02-27 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or quantitative metrics were disclosed in the provided filing information. Sector was not specified.

27-02-2026

NATURAL RESOURCE PARTNERS LP filed an 8-K on 2026-02-27 disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are mentioned. This is a standard earnings-related disclosure with no quantified financial impacts provided.

27-02-2026

ANI Pharmaceuticals Inc filed an 8-K on February 27, 2026 (AccNo: 0001023024-26-000013), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were explicitly stated in the provided filing details. This is a standard disclosure for financial results with no indicated positive or negative performance variations.

27-02-2026

Fulgent Genetics, Inc. filed a Form 8-K on February 27, 2026 (AccNo: 0001193125-26-079152), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but specific revenue, earnings, balance sheet details, guidance, or performance metrics are NOT_DISCLOSED. No positive, negative, or flat metrics, period-over-period comparisons, or other quantitative data are provided in the filing summary.

27-02-2026

1stdibs.com, Inc. filed an 8-K on February 27, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified metrics.

27-02-2026

TXNM Energy Inc filed an 8-K on February 27, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed financial data available.

27-02-2026

NIQ Global Intelligence plc filed a Form 8-K on 2026-02-27 under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are disclosed in the filing summary. This is a standard voluntary earnings-related disclosure without detailed financial data provided.

27-02-2026

Smurfit Westrock plc filed an 8-K on 2026-02-27 disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including key positions affected, individuals involved, reasons for change, appointment or resignation type, timing, or compensatory terms are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

27-02-2026

Nuveen Municipal Value Fund Inc filed a Form 8-K on February 27, 2026, under Item 8.01 Other Events. No specific details regarding the core event, transaction, financial metrics, positive or negative changes, or other quantitative data are disclosed in the filing summary provided. This appears to be a single-item voluntary or mandatory disclosure of a material event not covered by other Items, but content is limited.

27-02-2026

Johnson Outdoors Inc filed an 8-K on February 27, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material information via Regulation FD, with exhibits attached. No specific financial metrics, transactions, or quantitative data are disclosed in the provided filing details.

27-02-2026

Nuveen AMT-Free Municipal Value Fund filed a Form 8-K on February 27, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial metrics, transactions, or impacts are disclosed in the provided filing information. This appears to be a single-item, voluntary disclosure with no quantitative data available.

27-02-2026

Accelerant Holdings filed an 8-K on 2026-02-27 disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing details. This is a multi-item filing typical for earnings releases under Regulation FD.

27-02-2026

Roman DBDR Acquisition Corp. II filed an 8-K on 2026-02-27 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition event. The filing also includes Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific deal terms, financial metrics, parties involved, or quantitative details are disclosed.

27-02-2026

Zoomcar Holdings, Inc. filed a Form 8-K on February 27, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the content of the Regulation FD disclosure or the nature of the exhibits provided. No financial metrics, transactions, or performance data are disclosed in the filing summary.

27-02-2026

Healthpeak Properties, Inc. filed an 8-K on February 27, 2026, reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, or other specific events are detailed in the provided filing information. No positive or negative performance indicators are mentioned.

27-02-2026

Treace Medical Concepts, Inc. filed an 8-K on February 27, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard earnings-related disclosure. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are disclosed in the provided filing details.

27-02-2026

Alpha Metallurgical Resources, Inc. filed an 8-K on February 27, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material non-public information with attached exhibits such as press releases or presentations. No specific financial metrics, transaction details, guidance, or quantitative data are disclosed in the filing summary.

27-02-2026

National CineMedia, Inc. filed an 8-K on February 27, 2026, under Item 2.02 disclosing results of operations and financial condition. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are mentioned in the provided filing information. Detailed financial impacts remain NOT_DISCLOSED.

27-02-2026

TechTarget, Inc. filed an 8-K on February 27, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. Specific details including key positions affected, names, appointment or resignation status, reasons, timing, and any quantitative data are NOT_DISCLOSED.

27-02-2026

Alight, Inc. filed an 8-K on February 27, 2026 (AccNo: 0001193125-26-079261), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, individual names, appointment or resignation status, reasons for change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or market impacts are mentioned.

27-02-2026

Sunstone Hotel Investors, Inc. filed an 8-K on February 27, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

27-02-2026

MBX Biosciences, Inc. filed an 8-K on February 27, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details, numerical values, transaction sizes, personnel names, or financial impacts are provided in the filing summary.

27-02-2026

United States Brent Oil Fund, LP filed an 8-K on February 27, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, events, positive developments, negative changes, or flat performance indicators are disclosed in the provided filing information. Details of the Regulation FD disclosure and any attached exhibits are NOT_DISCLOSED.

27-02-2026

ALX Oncology Holdings Inc filed an 8-K on February 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative details were provided in the filing summary. This is an informational earnings-related disclosure with no directional financial impacts detailed.

27-02-2026

BlackRock TCP Capital Corp. filed an 8-K on February 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results disclosure. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed.

27-02-2026

United States 12 Month Natural Gas Fund, LP filed an 8-K on February 27, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information. This appears to be a voluntary disclosure of material information with attached exhibits.

27-02-2026

United States Gasoline Fund, LP filed a Form 8-K on February 27, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing summary. Critical content from the disclosure and exhibits is NOT_DISCLOSED.

27-02-2026

United States 12 Month Oil Fund, LP filed an 8-K on February 27, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing summary. This appears to be a voluntary informational filing with exhibits attached.

27-02-2026

United States Natural Gas Fund, LP filed an 8-K on February 27, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing summary. This appears to be a voluntary informational filing with exhibits attached.

27-02-2026

United States Oil Fund, LP filed an 8-K on February 27, 2026 (AccNo: 0001104659-26-021015, Size: 209 KB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, period-over-period comparisons, or other quantitative data are disclosed in the filing metadata. No positive or negative performance indicators are mentioned.

27-02-2026

Calumet, Inc. /DE filed an 8-K on 2026-02-27 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard financial results announcement, but specific revenue, earnings, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided filing details. No positive or negative metrics, transaction values, or operational changes were detailed.

27-02-2026

Globalstar, Inc. filed an 8-K on February 27, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance changes were disclosed in the provided filing information. No positive, negative, or flat metrics were mentioned.

27-02-2026

KORE Group Holdings, Inc. filed an 8-K on February 27, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, events, transaction value, financial metrics, or impacts are disclosed in the provided filing summary. All quantitative data, parties involved, and outcomes remain NOT_DISCLOSED.

27-02-2026

GLOBAL PARTNERS LP filed an 8-K on February 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided filing details. No positive or negative metrics are explicitly stated.

27-02-2026

United States Commodity Index Funds Trust filed an 8-K on February 27, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific events, transactions, financial metrics, or quantitative data are detailed in the filing summary provided. This appears to be a multi-item voluntary disclosure with attached exhibits.

27-02-2026

Criteo S.A. filed an 8-K on February 27, 2026, reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses shareholder vote matters and additional events, with exhibits attached, but no specific vote outcomes, event details, financial metrics, or quantitative data are provided in the filing summary. No positive or negative performance metrics reported.

27-02-2026

TransMedics Group, Inc. filed an 8-K on February 27, 2026 (AccNo: 0001193125-26-079392), reporting under Item 2.02 Results of Operations and Financial Condition, and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

27-02-2026

Enzon Pharmaceuticals, Inc. filed a Form 8-K on 2026-02-27 reporting entry into a material definitive agreement under Item 1.01 (potential strategic positive) but also material modifications to rights of security holders under Item 3.03 (potential negative for shareholders), alongside Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed. No positive or negative quantitative changes are mentioned.

27-02-2026

Amazon.com Inc filed an 8-K on February 27, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with the core event being a material definitive agreement, though specific details, transaction value, parties, and impacts are NOT_DISCLOSED. No financial metrics, guidance changes, or quantitative impacts are provided in the filing summary.

27-02-2026

DUOS Technologies Group, Inc. filed an 8-K on February 27, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. No specific details on positions affected, names, reasons for changes, financial metrics, or performance impacts are disclosed.

27-02-2026

Equinix Inc filed an 8-K on February 27, 2026, disclosing under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the exhibits are provided. This appears to be a voluntary informational filing with no quantitative metrics, events, or financial impacts mentioned.

27-02-2026

SIRIUS XM HOLDINGS INC. filed an 8-K on 2026-02-27 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. Filing size is 239 KB with AccNo: 0001104659-26-021044.

27-02-2026

LCI Industries filed a Form 8-K on February 27, 2026 (AccNo: 0000763744-26-000014, Size: 705 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the filing summary. This appears to be a multi-item voluntary disclosure with attached exhibits.

27-02-2026

CG Oncology, Inc. filed a Form 8-K on February 27, 2026 (AccNo: 0001193125-26-079452), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard voluntary earnings-related disclosure with no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons provided in the filing description. No quantitative metrics or directional performance indicators (positive, negative, or flat) are available.

27-02-2026

Arbor Realty Trust Inc filed an 8-K on February 27, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information.

27-02-2026

Assured Guaranty Ltd filed an 8-K on February 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, period-over-period changes, guidance, or quantitative data are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure without detailed performance indicators.